• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官转移中循环肿瘤细胞的特征、预后及T淋巴细胞介导的免疫反应

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.

作者信息

Sun Wen-Wen, Xu Zhi-Hong, Lian Peng, Gao Bei-Li, Hu Jia-An

机构信息

Department of Geriatrics.

Department of Respiration, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.

出版信息

Onco Targets Ther. 2017 May 4;10:2413-2424. doi: 10.2147/OTT.S130087. eCollection 2017.

DOI:10.2147/OTT.S130087
PMID:28496340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422503/
Abstract

Circulating tumor cells (CTCs) possess profound influence on tumor metastases and disease progression. This study aimed to investigate the correlation of CTCs with clinical characteristics and T-cell immunity, and to explore whether CTCs and the subpopulations can serve as an independent prognostic factor in advanced non-small cell lung cancer (NSCLC). A prospective study was conducted in late stages of NSCLC patients. The levels of overall CTCs and the three subpopulation CTCs were enumerated using the CanPatrol™ CTC enrichment system. The information about the patients which included the clinical characteristics, survival status at the 200th day postdiagnosis, and the levels of T cells was collected. Mann-Whitney test, Kruskal-Wallis test, Cox regression, and Spearman's rank correlation coefficient were the statistical methods used in this study. We detected CTCs in 27 of the 31 eligible patients; the level of epithelial-mesenchymal circulating tumor cells (EMCTCs) was higher than that of epithelial circulating tumor cells and that of mesenchymal circulating tumor cells (MCTCs) in the majority of NSCLC patients. Organ metastases were positively associated with the levels of overall CTCs, EMCTCs, and MCTCs (<0.05). EMCTCs and MCTCs were associated with worse clinical outcomes. Additionally, the levels of EMCTCs were negatively associated with the levels of CD3 T cells (=0.01) and CD8 T cells (=0.04). In conclusion, the levels of CTCs were positively associated with organ metastases, particularly bone metastases, but were negatively associated with T-cell levels. The levels of EMCTCs and MCTCs had negative prognostic value.

摘要

循环肿瘤细胞(CTCs)对肿瘤转移和疾病进展具有深远影响。本研究旨在探讨CTCs与临床特征及T细胞免疫的相关性,并探究CTCs及其亚群是否可作为晚期非小细胞肺癌(NSCLC)的独立预后因素。对NSCLC患者晚期进行了一项前瞻性研究。使用CanPatrol™ CTC富集系统对总CTCs水平及三个亚群CTCs水平进行计数。收集了患者的临床特征、诊断后第200天的生存状况以及T细胞水平等信息。本研究采用的统计方法包括曼-惠特尼检验、克鲁斯卡尔-沃利斯检验、Cox回归和Spearman等级相关系数。在31例符合条件的患者中,我们检测到27例存在CTCs;在大多数NSCLC患者中,上皮-间质循环肿瘤细胞(EMCTCs)水平高于上皮循环肿瘤细胞和间质循环肿瘤细胞(MCTCs)水平。器官转移与总CTCs、EMCTCs和MCTCs水平呈正相关(<0.05)。EMCTCs和MCTCs与较差的临床结局相关。此外,EMCTCs水平与CD3 T细胞水平(=0.01)和CD8 T细胞水平(=0.04)呈负相关。总之,CTCs水平与器官转移,尤其是骨转移呈正相关,但与T细胞水平呈负相关。EMCTCs和MCTCs水平具有负面预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/b3b892b0cb19/ott-10-2413Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/52337bdd243a/ott-10-2413Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/ce9c753de1b3/ott-10-2413Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/657de442fb05/ott-10-2413Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/b3b892b0cb19/ott-10-2413Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/52337bdd243a/ott-10-2413Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/ce9c753de1b3/ott-10-2413Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/657de442fb05/ott-10-2413Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8759/5422503/b3b892b0cb19/ott-10-2413Fig4.jpg

相似文献

1
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.器官转移中循环肿瘤细胞的特征、预后及T淋巴细胞介导的免疫反应
Onco Targets Ther. 2017 May 4;10:2413-2424. doi: 10.2147/OTT.S130087. eCollection 2017.
2
Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer.循环肿瘤细胞(CTCs)和 hTERT 基因在肺癌放疗效果中的表达。
BMC Cancer. 2023 May 24;23(1):475. doi: 10.1186/s12885-023-10979-z.
3
The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.循环肿瘤细胞和 T 淋巴细胞亚群在预测肺癌预后中的临床价值。
Clin Lab. 2024 Oct 1;70(10). doi: 10.7754/Clin.Lab.2024.230514.
4
Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.间充质循环肿瘤细胞(CTCs)和 CTC 中 OCT4 mRNA 表达对非小细胞肺癌患者预后预测的价值。
Clin Transl Oncol. 2017 Sep;19(9):1147-1153. doi: 10.1007/s12094-017-1652-z. Epub 2017 Apr 3.
5
Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer.循环肿瘤细胞在预测结直肠癌患者预后中的临床意义。
Clinics (Sao Paulo). 2022 Sep 7;77:100070. doi: 10.1016/j.clinsp.2022.100070. eCollection 2022.
6
Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.循环肿瘤细胞中环氧化酶-2表达与结直肠癌患者临床病理特征的关系。
J Cell Biochem. 2019 Apr;120(4):4935-4941. doi: 10.1002/jcb.27768. Epub 2018 Sep 27.
7
Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients.检测肺静脉中循环肿瘤细胞分子亚型对I-III期非小细胞肺癌患者预后的预测作用
Front Oncol. 2019 Oct 29;9:1139. doi: 10.3389/fonc.2019.01139. eCollection 2019.
8
Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.循环肿瘤细胞中间充质标志物和 LGR5 表达水平与结直肠癌预后相关。
Cell Oncol (Dordr). 2018 Oct;41(5):495-504. doi: 10.1007/s13402-018-0386-4. Epub 2018 Jun 14.
9
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.采用依赖和不依赖上皮标志物的方法分析非小细胞肺癌患者的循环肿瘤细胞。
J Thorac Oncol. 2012 Feb;7(2):306-15. doi: 10.1097/JTO.0b013e31823c5c16.
10
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.基于上皮-间充质转化标志物的循环肿瘤细胞表型检测在 HER2 阴性转移性乳腺癌一线化疗中的预后和治疗意义。
Cancer Commun (Lond). 2019 Jan 3;39(1):1. doi: 10.1186/s40880-018-0346-4.

引用本文的文献

1
Role of long noncoding RNAs in the regulation of epithelial‑mesenchymal transition in osteosarcoma (Review).长链非编码RNA在骨肉瘤上皮-间质转化调控中的作用(综述)
Oncol Rep. 2025 Mar;53(3). doi: 10.3892/or.2025.8868. Epub 2025 Jan 24.
2
Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer.循环肿瘤细胞(CTCs)和 hTERT 基因在肺癌放疗效果中的表达。
BMC Cancer. 2023 May 24;23(1):475. doi: 10.1186/s12885-023-10979-z.
3
Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies.

本文引用的文献

1
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.T细胞的氧感知建立了免疫耐受的转移微环境。
Cell. 2016 Aug 25;166(5):1117-1131.e14. doi: 10.1016/j.cell.2016.07.032.
2
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.循环肿瘤细胞(CTC)与炎性乳腺癌患者适应性免疫缺陷相关。
J Cancer. 2016 Jun 3;7(9):1095-104. doi: 10.7150/jca.13098. eCollection 2016.
3
Characterization of different CTC subpopulations in non-small cell lung cancer.
利用基于微流控技术解析癌症转移级联反应。
Biophys Rev. 2022 Apr 14;14(2):517-543. doi: 10.1007/s12551-022-00944-8. eCollection 2022 Apr.
4
Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy.循环肿瘤细胞的间充质特征及预测生物标志物用于治疗策略
Cancers (Basel). 2020 Nov 30;12(12):3588. doi: 10.3390/cancers12123588.
5
Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?循环肿瘤细胞的单细胞分析:在组学时代我们已经走了多远?
Front Genet. 2019 Oct 17;10:958. doi: 10.3389/fgene.2019.00958. eCollection 2019.
6
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity.循环肿瘤细胞作为评估肿瘤异质性的工具。
Theranostics. 2019 Jun 19;9(16):4580-4594. doi: 10.7150/thno.34337. eCollection 2019.
7
Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.液体活检中通过结合 CTCs 和相关外周血细胞进行癌症综合诊断。
Clin Transl Oncol. 2019 Jul;21(7):828-835. doi: 10.1007/s12094-018-02004-8. Epub 2018 Dec 19.
8
Immune cells inhibit the tumor metastasis in the 4D cellular lung model by reducing the number of live circulating tumor cells.免疫细胞通过减少循环肿瘤细胞的数量来抑制 4D 细胞肺部模型中的肿瘤转移。
Sci Rep. 2018 Nov 8;8(1):16569. doi: 10.1038/s41598-018-34983-7.
9
Roles of the immune system in cancer: from tumor initiation to metastatic progression.免疫系统在癌症中的作用:从肿瘤起始到转移进展。
Genes Dev. 2018 Oct 1;32(19-20):1267-1284. doi: 10.1101/gad.314617.118.
10
The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy.循环肿瘤细胞与免疫系统之间的相互作用:从免疫逃逸到癌症免疫治疗
Diagnostics (Basel). 2018 Aug 30;8(3):59. doi: 10.3390/diagnostics8030059.
非小细胞肺癌中不同循环肿瘤细胞亚群的特征分析
Sci Rep. 2016 Jun 15;6:28010. doi: 10.1038/srep28010.
4
A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.循环肿瘤细胞计数与非小细胞肺癌患者临床特征关系的初步研究。
Ann Transl Med. 2015 Dec;3(22):352. doi: 10.3978/j.issn.2305-5839.2015.11.18.
5
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.IASLC 肺癌分期项目:对即将发布的(第八版)肺癌 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.
6
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.肿瘤微环境中的代谢竞争是癌症进展的驱动因素。
Cell. 2015 Sep 10;162(6):1229-41. doi: 10.1016/j.cell.2015.08.016. Epub 2015 Aug 27.
7
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.在转移性前列腺癌患者多西他赛治疗期间,将分类计数与连续计数循环肿瘤细胞作为治疗反应和预后的早期替代标志物。
BMC Cancer. 2015 Jun 9;15:458. doi: 10.1186/s12885-015-1478-4.
8
Classification of circulating tumor cells by epithelial-mesenchymal transition markers.通过上皮-间质转化标志物对循环肿瘤细胞进行分类。
PLoS One. 2015 Apr 24;10(4):e0123976. doi: 10.1371/journal.pone.0123976. eCollection 2015.
9
Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer.晚期结直肠癌四药方案II期试验中的循环肿瘤细胞计数
Clin Colorectal Cancer. 2015 Jun;14(2):115-22.e1-2. doi: 10.1016/j.clcc.2014.12.006. Epub 2014 Dec 31.
10
Immune cell promotion of metastasis.免疫细胞对转移的促进作用。
Nat Rev Immunol. 2015 Feb;15(2):73-86. doi: 10.1038/nri3789.